Suzhou Basecare Secures Deal with Gattaca Genomics
Company Announcements

Suzhou Basecare Secures Deal with Gattaca Genomics

Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170) has released an update.

Suzhou Basecare Medical Corporation Limited has announced a significant business development, having entered into a two-year sale and purchase agreement through its subsidiary Genea Biomedx with Gattaca Genomics LLC, to supply innovative Geri Time-Lapse Incubators and related products. The deal is expected to boost Genea Biomedx’s market presence by expanding its installed base and creating opportunities for cross-selling. This strategic move is anticipated to benefit the company and its shareholders by enhancing its position in the reproductive health industry.

For further insights into HK:2170 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App